Robey RW - Search Results

1

Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.

Bahr JC, Robey RW, Luchenko V, Basseville A, Chakraborty AR, Kozlowski H, Pauly GT, Patel P, Schneider JP, Gottesman MM, Bates SE. Bahr JC, et al. Among authors: robey rw. Oncotarget. 2016 Oct 25;7(43):69804-69815. doi: 10.18632/oncotarget.12001. Oncotarget. 2016. PMID: 27634878 Free PMC article.

2

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Among authors: robey rw. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

3

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: robey rw. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

4

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

5

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.

Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. Lee JS, et al. J Cell Biochem. 1997 Jun 15;65(4):513-26. J Cell Biochem. 1997. PMID: 9178101

6

Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833.

Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S, Smith T, Fojo T, Bates S. Robey R, et al. Blood. 1999 Jan 1;93(1):306-14. Blood. 1999. PMID: 9864175 Free article. Clinical Trial.

7

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T, Bates SE. Miyake K, et al. Cancer Res. 1999 Jan 1;59(1):8-13. Cancer Res. 1999. PMID: 9892175

8

Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.

Brangi M, Litman T, Ciotti M, Nishiyama K, Kohlhagen G, Takimoto C, Robey R, Pommier Y, Fojo T, Bates SE. Brangi M, et al. Cancer Res. 1999 Dec 1;59(23):5938-46. Cancer Res. 1999. PMID: 10606239

9

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

de Bruin M, Miyake K, Litman T, Robey R, Bates SE. de Bruin M, et al. Cancer Lett. 1999 Nov 15;146(2):117-26. doi: 10.1016/s0304-3835(99)00182-2. Cancer Lett. 1999. PMID: 10656616

10

Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs.

Blagosklonny MV, Robey R, Bates S, Fojo T. Blagosklonny MV, et al. J Clin Invest. 2000 Feb;105(4):533-9. doi: 10.1172/JCI8625. J Clin Invest. 2000. PMID: 10683383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters